July 16, 2018
Article
An Extraordinary Healer essay honoring JENNI CHANG, B.S.N., RN, OCN [VA PALO ALTO HEALTH CARE SYSTEM, PALO ALTO, CALIFORNIA]
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC